Details of the Drug Reposition

General Information of This Drug (ID: DM4S5UO)

Drug Name
NDV-3A   DM4S5UO
Drug Type
Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Staphylococcus infection DISY8WGS 1B5Y Phase 2 [1]
Vulvovaginal Candidiasis DISRCR6D 1F23.10 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03455309) Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01926028) Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis. U.S. National Institutes of Health.